rs376280361
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM5BS2
The ENST00000326873.12(STK11):c.911G>A(p.Arg304Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,570,750 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R304P) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000326873.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.911G>A | p.Arg304Gln | missense_variant | 7/10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.911G>A | p.Arg304Gln | missense_variant | 7/9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.2178G>A | non_coding_transcript_exon_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.911G>A | p.Arg304Gln | missense_variant | 7/10 | 1 | NM_000455.5 | ENSP00000324856 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000387 AC: 7AN: 180804Hom.: 0 AF XY: 0.0000410 AC XY: 4AN XY: 97514
GnomAD4 exome AF: 0.0000176 AC: 25AN: 1418518Hom.: 0 Cov.: 30 AF XY: 0.0000142 AC XY: 10AN XY: 701900
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74378
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Oct 27, 2023 | This missense variant replaces arginine with glutamine at codon 304 of the STK11 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with STK11-related disorders in the literature. This variant has been identified in 7/180804 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Different missense variants occurring at the same position, p.Arg304Trp and p.Arg304Pro, are known to be pathogenic (Clinvar variation ID: 183802, 428783), indicating that arginine at this position is important for STK11 function. Due to the lack of clinical data, the available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 304 of the STK11 protein (p.Arg304Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with STK11-related conditions. ClinVar contains an entry for this variant (Variation ID: 419419). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STK11 protein function with a negative predictive value of 80%. This variant disrupts the p.Arg304 amino acid residue in STK11. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9809980, 10441497, 12552571, 12865922, 15121768, 17404884). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | Jul 02, 2018 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jul 19, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 29, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 9809980, 17404884, 15121768, 12865922, 12552571, 10441497, 35264596, 15863673, 33471991) - |
Hereditary cancer-predisposing syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The p.R304Q variant (also known as c.911G>A), located in coding exon 7 of the STK11 gene, results from a G to A substitution at nucleotide position 911. The arginine at codon 304 is replaced by glutamine, an amino acid with highly similar properties. In one study, this variant was reported in 1/60,466 breast cancer cases and in 0/53,461 controls (Dorling et al. N Engl J Med. 2021 02;384:428-439). Two other missense alterations at the same codon, p.R304W and p.R204P, have been reported in individuals with Peutz-Jeghers syndrome (Resta N et al. Cancer Res. 1998;58(21):4799; Lim W et al. Br J Cancer. 2003;89:308-313; Schumacher V et al. J Med Genet. 2005;42(5):428-35; Aretz S et al. Hum Mutat. 2005 Dec;26(6):513-9; Salloch H et al. Int J Colorectal Dis. 2010;25(1):97-107; Amos CI et al. J Med Genet. 2006;41(5):327-333); however, p.R304Q has been identified in numerous individuals without features of PJS (Ambry Internal Data). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence for this variant is limited at this time, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Sep 27, 2023 | This missense variant replaces arginine with glutamine at codon 304 of the STK11 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with STK11-related disorders in the literature. This variant has been identified in 7/180804 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Different missense variants occurring at the same position, p.Arg304Trp and p.Arg304Pro, are known to be pathogenic (Clinvar variation ID: 183802, 428783), indicating that arginine at this position is important for STK11 function. Due to the lack of clinical data, the available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Feb 06, 2024 | - - |
STK11-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 05, 2023 | The STK11 c.911G>A variant is predicted to result in the amino acid substitution p.Arg304Gln. This variant was reported in an individual with breast cancer and interpreted as uncertain (Table S3 Guindalini et al 2022. PubMed ID: 35264596). Two different missense change at the same amino acid position, c.910C>T (Arg304Trp) and c.911G>C (Arg304Pro), have been reported in patients with colon cancer and Peutz-Jeghers Syndrome (Resta et al. 1998. PubMed ID: 9809980; Boudeau et al. 2003. PubMed ID: 12552571; Mehenni et al. 2007. PubMed ID: 17404884, Aretz et al. 2005. PubMed ID: 16287113, Jiang et al. 2018. PubMed ID: 30092773). The c.911G>A variant is reported in 0.018% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-1221996-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at